Allogene Therapeutics, Inc.盘中异动股价大涨5.99%

市场透视2025-05-15

北京时间2025年05月15日21时58分，Allogene Therapeutics, Inc.（ALLO.us）股票出现波动，股价大幅拉升5.99%。截至发稿，该股报1.010美元/股，成交量46.9858万股，换手率0.21%，振幅6.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-59.73百万美元，每股收益-0.28美元，毛利-3.10百万美元，市盈率-0.82倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535829733?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-15 21:58","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535829733","market":"us","top_or_hot":-1,"title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.99%","media":"市场透视","content":"<div>\n<p>北京时间2025年05月15日21时58分，Allogene Therapeutics, Inc.（ALLO.us）股票出现波动，股价大幅拉升5.99%。截至发稿，该股报1.010美元/股，成交量46.9858万股，换手率0.21%，振幅6.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-59.73百万美元，每股收益-0.28美元，毛利-3.10百万美元，市盈率-0.82倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215802aa2c8fe2&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Allogene Therapeutics, Inc.盘中异动 股价大涨5.99%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAllogene Therapeutics, Inc.盘中异动 股价大涨5.99%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-15 21:58 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215802aa2c8fe2&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月15日21时58分，Allogene Therapeutics, Inc.（ALLO.us）股票出现波动，股价大幅拉升5.99%。截至发稿，该股报1.010美元/股，成交量46.9858万股，换手率0.21%，振幅6.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-59.73百万美元，每股收益-0.28美元，毛利-3.10百万美元，市盈率-0.82倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215802aa2c8fe2&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215802aa2c8fe2&s=b","article_id":"2535829733","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515215802aa2c8fe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535829733","pubTimestamp":1747317481,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月15日21时58分，Allogene Therapeutics, Inc.股票出现波动，股价大幅拉升5.99%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc 是一家临床阶段的生物技术公司，专门从事免疫肿瘤学，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。消息层面，截至21时58分，《Piper Sandler：维持Allogene Therapeutics评级，由增持调整至增持评级, 目标价由9.00美元调整至7.00美元。》资讯为影响Allogene Therapeutics, Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","BK4139":"生物科技","BK4505":"高瓴资本持仓","BK4007":"制药","BK4539":"次新股","ALLO":"Allogene Therapeutics Inc."},"translate_title":"Allogene Therapeutics, Inc. stock jumps 5.99% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALLO":0.9,"LENZ":1},"content_text":"北京时间2025年05月15日21时58分，Allogene Therapeutics, Inc.（ALLO.us）股票出现波动，股价大幅拉升5.99%。截至发稿，该股报1.010美元/股，成交量46.9858万股，换手率0.21%，振幅6.19%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-59.73百万美元，每股收益-0.28美元，毛利-3.10百万美元，市盈率-0.82倍。机构评级方面，在所有14家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Nucana Plc、Werewolf Therapeutics, Inc.、Abpro Holdings, Inc涨幅较大，Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃，换手率分别为9002.41%、2400.58%、283.41%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Nucana Plc、Protagenic Therapeutics Inc C/Wts 26/04/2026 (To Pur Com)，振幅分别为75.38%、41.33%、39.71%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc 是一家临床阶段的生物技术公司，专门从事免疫肿瘤学，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。他们的产品线包括现成的 T 细胞候选细胞，旨在靶向自身免疫性疾病中的癌细胞或自身反应细胞。值得注意的是，他们来自健康捐献者的同种异体方法允许更广泛的患者资格和可扩展性。公司以重新定义 CAR T 疗法为愿景，专注于针对淋巴瘤、白血病、自身免疫性疾病和实体瘤的核心项目。来自合作和许可协议的收入支持他们的研发工作。消息层面，截至21时58分，《Piper Sandler：维持Allogene Therapeutics评级，由增持调整至增持评级, 目标价由9.00美元调整至7.00美元。》资讯为影响Allogene Therapeutics, Inc.的重要信息。该信息摘要如下：Piper Sandler：维持Allogene Therapeutics(ALLO.US)评级，由增持调整至增持评级, 目标价由9.00美元调整至7.00美元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535829733","isCrawlerRequest":true}

Allogene Therapeutics, Inc.盘中异动 股价大涨5.99%

精彩评论

Allogene Therapeutics, Inc.盘中异动股价大涨5.99%